0 Items - $0.00
A to Z

Alternative structural projections:


N², 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ), sodium salt
Metabolically activatable PKG agonist
Cat. No.: D 010
CAS No.: [51116-00-8]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: D 010-50
Unit: 50 µmol / ~25 mg
For other salt forms please inquire. Caution: We do not recommend this cGMP analogue due to its lacking potency and selectivity. The metabolically released N2-monobutyryl cGMP is only a poor activator of cGMP- dependent protein kinase, and released butyrate can have its own side effects leading to misinterpretation of experimental results. Ref.: Butt et al., Biochem. Pharmacol., 43, 2591 - 2600 (1992). We offer numerous more recommendable cGMP agonists; e.g. 8-pCPT-cGMP (Cat. No. C 009), is a much better choice. Detailed technical information available.
Cat. No. D 010
CAS number [51116-00-8]
Purity > 97% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Molecular formula C₁₈H₂₃N₅O₉P · Na
Molecular weight [g/mol] 507,4
Modifications 2-cGMP, 2'-cGMP
Target PKG (cGK) Activator
Lipophilicity 2.58
Absorption max [nm] 256
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 16700